Exact Mass: 328.15487520000005
Exact Mass Matches: 328.15487520000005
Found 188 metabolites which its exact mass value is equals to given mass value 328.15487520000005,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methotrimeprazine
Methotrimeprazine is only found in individuals that have used or taken this drug. It is a phenothiazine with pharmacological activity similar to that of both chlorpromazine and promethazine. It has the histamine-antagonist properties of the antihistamines together with central nervous system effects resembling those of chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)Methotrimeprazines antipsychotic effect is largely due to its antagonism of dopamine receptors in the brain. In addition, its binding to 5HT2 receptors may also play a role. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics KEIO_ID M099; [MS2] KO009123 KEIO_ID M099 Levomepromazine (Methotrimeprazine) is an orally available neuroleptic agent, which is commonly used to relieve nausea and vomiting in palliative care settings. Levomepromazine has antagonist actions at multiple neurotransmitter receptor sites, including dopaminergic, cholinergic, serotonin and histamine receptors[1].
Carteolol hydrochloride
C16H25ClN2O3 (328.15536099999997)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Carteolol hydrochloride (OPC-1085 hydrochloride) is a non-selective beta blocker used to treat glaucoma.
Tiapride
C15H24N2O4S (328.14567040000003)
Tiapride is a benzamide derivative with dopamine antagonist actions similar to sulpiride. It has been used as an antipsychotic and in the treatment of various movement disorders and alcoholism. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Perilloside B
Perilloside B is found in herbs and spices. Perilloside B is a constituent of perilla (Perilla frutescens). Constituent of perilla (Perilla frutescens). Perilloside B is found in herbs and spices.
3-Hydroxy-4-isopropylbenzyl alcohol 3-glucoside
3-Hydroxy-4-isopropylbenzyl alcohol 3-glucoside is a constituent of fruit of Carum ajowan (ajowan). Constituent of fruit of Carum ajowan (ajowan)
Cymorcin monoglucoside
Cymorcin monoglucoside is a constituent of the seeds of Carum copticum (ajowan) Constituent of the seeds of Carum copticum (ajowan).
Litcubine
C19H22NO4+ (328.15487520000005)
Litcubine is found in fruits. Litcubine is an alkaloid from the roots of Litsea cubeba (mountain pepper
1-[10-[3-(Dimethylamino)propyl]phenothiazin-2-yl]ethanol
Eplivanserin
C19H21FN2O2 (328.15869779999997)
Levopromazine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
6-[(1R,2R,3S,5S)-2-[(Z)-4-Carboxybut-2-enyl]-3,5-dihydroxycyclopentyl]-4-oxohexanoic acid
1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanol
(2S,3R,4S,5S,6R)-2-[4-(3-hydroxybutyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
8-hydroxycuminyl beta-D-glucopyranoside|8-Hydroxycuminyl ??-D-glucopyranoside
3-(beta-D-Glucopyranosyloxymethyl)-2,4,4-trimethyl-2,5-cyclohexadien-1-one
1,1,5-trimethyl-2-hydroxymethyl-(2,5)-cyclohexadien-(4)-one-O-beta-D-glucopyranoside|1,1,5-trimethyl-2-hydroxymethyl-2,5-cyclohexadien-4-one-O-beta-D-glucopyranoside
(2R,3R)-1-phenyl-2,3-butanediol 2-O-beta-D-glucopyranoside|everlastoside I
5-(1,5-dimethyl-3,4,8-trihydroxy-6-methoxy-7-oxabicyclo-[3,2,1]-oct-8-yl)-3-methyl-2,4pentadienoic acid
beta-D-glucopyranosyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate|jasminoside J
(8R)-9-hydroxycuminyl beta-D-glucopyranoside|(8R)-9-Hydroxycuminyl ??-D-glucopyranoside
(2S,3S)-1-phenyl-2,3-butanediol 3-O-beta-D-glucopyranoside|(2S,3S)-1-Phenyl-2,3-butanediol 3-O-??-D-glucopyranoside
tiapride
C15H24N2O4S (328.14567040000003)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist CONFIDENCE standard compound; INTERNAL_ID 2278 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3028
2-hydroxy-2-[2-oxo-2-[(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)oxy]ethyl]butanedioic acid
C16H24O7_4-(3-Hydroxybutyl)phenyl beta-D-glucopyranoside
C16H24O7_beta-D-Glucopyranoside, 5-(hydroxymethyl)-2-(1-methylethyl)phenyl
C16H24O7_beta-D-Glucopyranoside, 4-hydroxy-2-methyl-5-(1-methylethyl)phenyl
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxy-2-methyl-5-propan-2-ylphenoxy)oxane-3,4,5-triol
Levomepromazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Levomepromazine (Methotrimeprazine) is an orally available neuroleptic agent, which is commonly used to relieve nausea and vomiting in palliative care settings. Levomepromazine has antagonist actions at multiple neurotransmitter receptor sites, including dopaminergic, cholinergic, serotonin and histamine receptors[1].
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxy-2-methyl-5-propan-2-ylphenoxy)oxane-3,4,5-triol_major
(2S,3R,4S,5S,6R)-2-[4-(3-hydroxybutyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
9,15-dioxo-11R-hydroxy-2,3,4,5-tetranor-prostan-1,20-dioic acid
Cymorcin monoglucoside
Litcubine
C19H22NO4 (328.15487520000005)
3-Hydroxy-4-isopropylbenzyl alcohol 3-glucoside
Perilloside B
Phencarbamide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
tert-Butyl 5-methyl-3-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate
C18H24N2O2Si (328.16069639999995)
Imazaquin ammonium
C17H20N4O3 (328.15353300000004)
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
n,n-diethyl-4-[(2-methoxy-4-nitro)phenylazo]aniline
C17H20N4O3 (328.15353300000004)
Eplivanserin
C19H21FN2O2 (328.15869779999997)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
[4-(4-fluoro-phenyl)-piperazin-1-yl]-p-tolyl-acetic acid
C19H21FN2O2 (328.15869779999997)
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose 1-(2-methyl-2-propenoate)
6-[[(1,1-Dimethylethoxy)carbonyl]amino]hexanoic acid 2,5-dioxo-1-pyrrolidinyl ester
Methyl 2-(4-Benzylpiperazino)-5-fluorobenzoate
C19H21FN2O2 (328.15869779999997)
4-[(3r)-3-{[2-(4-Fluorophenyl)-2-Oxoethyl]amino}butyl]benzamide
C19H21FN2O2 (328.15869779999997)
Salutaridinium(1+)
C19H22NO4+ (328.15487520000005)
The conjugate acid of salutaridine; major species at pH 7.3.
(6aS)-2,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-6-ium-1,11-diol
C19H22NO4+ (328.15487520000005)
3-[(2S,4S)-2,4-dimethylhexanoyl]-5-(4-hydroxyphenyl)-2-oxo-1H-pyridin-4-olate
C19H22NO4- (328.15487520000005)
7-[2-(3-carboxypropyl)-3-oxocyclopentyl]-7-hydroxy-5-oxoheptanoic acid
2-[(2-Acetyloxy-3-ethoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
6-[2-[(E)-4-carboxybut-2-enyl]-3,5-dihydroxycyclopentyl]-4-oxohexanoic acid
Naloxone(1+)
C19H22NO4+ (328.15487520000005)
An ammonium ion resulting from the protonation of the nitrogen of naloxone.
3,4,5-trihydroxy-2-(2-phenylhydrazono)pentanal N-phenylhydrazone
C17H20N4O3 (328.15353300000004)
[4-(2-Methylphenyl)-1-piperazinyl]-(5-propyl-3-thiophenyl)methanone
2-Butyl-3-[(3-chlorophenyl)methyl]-5-methyl-6-imidazo[4,5-b]pyridinamine
1,9,10-Trihydroxy-2-methoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-6-ium
C19H22NO4+ (328.15487520000005)
N-tert-butyl-2-hydroxy-3-[(2-oxo-1,2,3,4-tetrahydroquinolin-5-yl)oxy]propan-1-aminium chloride
C16H25ClN2O3 (328.15536099999997)
N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2S,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
N-[(2R,3S,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-1-phenylmethanesulfonamide
C15H24N2O4S (328.14567040000003)
[O-(1-O-Ethyl-2-O-acetyl-L-glycero-3-phospho)choline]anion
2-[[(2R)-3-butanoyloxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-butanoyloxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-Isopropyl-5-(hydroxymethyl)phenyl beta-D-glucopyranoside
2-Hydroxy-2-[2-oxo-2-[(4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl)oxy]ethyl] butanedioic acid
8,13-Dioxo-5,6,7,8,13,14,15,16-octahydro-6,15-methanobenzo(A)naphtho(2,3-F)cyclodecene
9,12-Dioxo-5,6,7,9,12,14,15,16-octahydro-6,15-methanobenzo(A)naphtho(2,3-F)cyclodecene
2-[(3-Butanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
reticulinylium
C19H22NO4+ (328.15487520000005)
A benzylisoquinoline alkaloid that is obtained by selective dehydrogenation at the 1,2-position of reticuline.
prostaglandin E2-UM
A prostanoid that is prostaglandin E2 in which the acyclic hydroxy group has been oxidised to the corresponding ketone, the methyl group has been oxidised to the corresponding carboxylic acid and the 6-carboxyhexenyl group has been oxidatively cleaved to a 2-carboxyethyl group. It is the major urinary metabolite of prostaglandin E2.
(2e,4e)-3-methyl-5-[(1s,2s,3r,5r,7r,8s)-2,3,8-trihydroxy-7-methoxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl]penta-2,4-dienoic acid
2-(2-hydroxy-5-isopropyl-4-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(7s,12ar)-2,9-dihydroxy-3,10-dimethoxy-7-methyl-5h,6h,12h,12ah-indolo[2,1-a]isoquinolin-7-ium
[C19H22NO4]+ (328.15487520000005)
2,4,4-trimethyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohexa-2,5-dien-1-one
2-methyl-10-(3-methylbut-2-en-1-yl)-5,10-diazatetraphen-12-one
(4s,8r,13r,16r)-4,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione
3-methyl-5-[(1s,2s,3r,5r,7r,8s)-2,3,8-trihydroxy-7-methoxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl]penta-2,4-dienoic acid
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4s)-4-(prop-1-en-2-yl)cyclohex-1-ene-1-carboxylate
2-(4-hydroxy-2-isopropyl-5-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-(2-hydroxy-5-isopropyl-4-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,4s)-4-(acetyloxy)-5-[(1s,3s,5r)-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-3-yl]pentan-2-yl acetate
(3r,4s,5s,6r)-2-(2-hydroxy-6-isopropyl-3-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-isopropyl-5-methyl-1,4-benzenediol; 5-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN005854","Ingredient_name": "2-isopropyl-5-methyl-1,4-benzenediol; 5-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H24O7","Ingredient_Smile": "NA","Ingredient_weight": "328.36","OB_score": "NA","CAS_id": "95645-53-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8600","PubChem_id": "NA","DrugBank_id": "NA"}
7-hydroxythymol 3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN013291","Ingredient_name": "7-hydroxythymol 3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H24O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10763","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-hydroxycuminyl β-d-glucopyranoside
{"Ingredient_id": "HBIN013776","Ingredient_name": "8-hydroxycuminyl \u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H24O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9949","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(8r)-9-hydroxycuminyl β-d-glucopyranoside
{"Ingredient_id": "HBIN013895","Ingredient_name": "(8r)-9-hydroxycuminyl \u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H24O7","Ingredient_Smile": "CC(CO)C1=CC=C(C=C1)COC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9950","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[5-(2-hydroxypropan-2-yl)-2-methylphenoxy]oxane-3,4,5-triol
2-(hydroxymethyl)-6-[2-(hydroxymethyl)-5-isopropylphenoxy]oxane-3,4,5-triol
2-(hydroxymethyl)-5-(4-hydroxyphenoxy)-6-(sec-butoxy)oxane-3,4-diol
2,3,11-trihydroxy-5-(hydroxymethyl)-11-isopropyl-7-methoxy-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undec-4-en-10-one
(2s,3r,4s,5s,6r)-2-(4-hydroxy-2-isopropyl-5-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s,4s,5r,6r)-6-[(2r)-butan-2-yloxy]-2-(hydroxymethyl)-5-(4-hydroxyphenoxy)oxane-3,4-diol
(2r,3r,4s,5s,6r)-2-{[(2s,3s)-3-hydroxy-4-phenylbutan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2,4,4-trimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohexa-2,5-dien-1-one
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2s)-4-(4-hydroxyphenyl)butan-2-yl]oxy}oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-methoxy-4-propylphenoxy)oxane-3,4,5-triol
2,4,4-trimethyl-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohexa-2,5-dien-1-one
(12ar)-2,9-dihydroxy-3,10-dimethoxy-7-methyl-5h,6h,12h,12ah-indolo[2,1-a]isoquinolin-7-ium
[C19H22NO4]+ (328.15487520000005)
5-methyl-2-[(2r)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl]cyclohexa-2,5-dien-1-one
(4r,8r,13r,16r)-4,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione
2-(hydroxymethyl)-6-[5-(2-hydroxypropan-2-yl)-2-methylphenoxy]oxane-3,4,5-triol
(2r,4r)-4-(acetyloxy)-5-[(1r,3s,5s)-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-3-yl]pentan-2-yl acetate
(3r,4s,5s,6r)-2-(4-hydroxy-2-isopropyl-5-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-(hydroxymethyl)-6-[2-(hydroxymethyl)-3-propylphenoxy]oxane-3,4,5-triol
2-(hydroxymethyl)-6-(2-methoxy-4-propylphenoxy)oxane-3,4,5-triol
2,4,4-trimethyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohexa-2,5-dien-1-one
5,5-dimethyl-4-methylidene-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
(2r,3r,4s,5s,6r)-2-{[(2r,3r)-3-hydroxy-1-phenylbutan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(2-hydroxy-6-propylphenyl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)-5-isopropylphenoxy]oxane-3,4,5-triol
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate
2-(4-hydroxy-5-isopropyl-2-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-(4-hydroxy-3-isopropyl-2-methylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-[(2s)-2-(2-hydroxy-4-methylphenyl)propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4,5,16-trihydroxy-15-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-ium
[C19H22NO4]+ (328.15487520000005)